ProCE Banner Activity

Clinical Development of Selective CDK4/6 Inhibitors: Monotherapy Activity and Mechanisms of Resistance

Slideset Download
The second of 3 downloadable slidesets from a satellite symposium at the 2017 annual meeting in Chicago: Richard Finn, MD; Gary K. Schwartz, MD; and Geoffrey Shapiro, MD, PhD, review critical studies on the clinical and preclinical characteristics of CDK4/6 inhibitors in multiple tumor types.

Released: June 08, 2017

Expiration: June 07, 2018

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.